James R. Bush

James R. Bush, MBA, currently serves as Executive Director of CMC Regulatory Affairs at Dyne Therapeutics, a position held since April 2021, and previously occupied various roles including Senior Director in the same department. Prior experience includes positions at Pfizer as Director, Array BioPharma Inc. as Director of CMC Regulatory Affairs, Wave Life Sciences as Associate Director of Regulatory Affairs CMC, and Syner-G Pharma CMC Consulting, LLC in multiple regulatory affairs roles. James also worked at Vertex Pharmaceuticals, contributing significantly to CMC strategies and regulatory submissions for critical programs, and held earlier analytical development roles at Infinity Pharmaceuticals and AMAG Pharmaceuticals. James R. Bush holds an MBA in Business Analytics and Healthcare from Babson College and a Bachelor of Science in Biochemistry from Union College.